MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor

Stock Information for MEI Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MEI Pharma Inc.

The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors
MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position
MEI Pharma Reports Fiscal Year End 2024 Cash Position
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
MEI Pharma to Consider Strategic Alternatives
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.